NDA 203195 · Lupin LTD
Suprax
Cefixime · Oral
Last checked: Nov 20, 2026Latest source record: May 22, 2025 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2012
Jun 1, 2012
Approved uses
1
Original approval plus efficacy supplements
Registered trials
46
6 Phase 3, 6 recruiting
FAERS reports
3,061
2,619 serious, 212 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Aug 5, 2026.
Cefixime is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months and older with the following infections: Uncomplicated Urinary Tract Infections ( 1.1 ) Otitis Media ( 1.2 ) Pharyngitis and Tonsillitis ( 1.3 ) Acute Exacerbations of Chronic Bronchitis ( 1.4 ) Uncomplicated Gonorrhea (cervical/urethral) ( 1.5 ) Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefixime and other antibacterial drugs, cefixime for oral suspension and cefixime capsules should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. ( 1.6 ) 1.1 Uncomplicated Urinary Tract Infections Cefixime for oral suspension and cefixime capsule is indicated in the treatment of adults and pediatric patients six months of age or older with uncomplicated urinary tract infections caused by susceptible isolates of Escherichia coli and Proteus mirabilis . 1.2 Otitis Media Cefixime for oral suspension and cefixime capsule is indicated in the treatment of adults and pediatric patients six months of age or older with otitis media caused by susceptible isolates of Haemophilus influenzae , Moraxella catarrhalis , and Streptococcus pyogenes . (Efficacy for Streptococcus pyogenes in this organ system was studied in fewer than 10 infections.) Note: For patients with otitis media caused by Streptococcus pneumoniae , overall response was approximately 10% lower for cefixime than for the comparator [see Clinical Studies ( 14 )] . 1.3 Pharyngitis and Tonsillitis Cefixime for oral suspension and cefixime capsule is indicated in the treatment of adults and pediatric patients six months of age or older with pharyngitis and tonsillitis caused...
Mechanism: Cefixime is a semisynthetic cephalosporin antibacterial drug [see Microbiology ( 12.4 )] .
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jun 1, 2012 Original approval · Type 3 - New Dosage Form LabelReviewSummary Review
1 products under this application
- SUPRAX · CEFIXIME 400MG · CAPSULE, ORAL · Prescription · TE AB
Clinical trials
Interventional ClinicalTrials.gov studies with "Cefixime" as an intervention, any sponsor and status, largest first.
- Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSMPivotal-lookingActive, not recruiting
University of WashingtonAcademic, hospital or other
NCT06468462 · 2,900 participants (planned) · Start Oct 29, 2025 · Primary completion Oct 31, 2028
Drug: WHO-recommended periodic presumptive treatment; Doxycycline post-exposure prophylaxis · For: Gonorrhea Male; Chlamydia (Male); Syphilis Male
Sites: Kisumu, Kenya; Mombasa, Kenya; Nairobi, Kenya
- The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)Pivotal-lookingCompleted
Oxford University Clinical Research Unit, VietnamAcademic, hospital or other
NCT04349826 · 2,150 participants · Start May 23, 2021 · Primary completion Dec 31, 2025
Drug: Azithromycin; Cefixime and 1 more · For: Typhoid Fever
Sites: Lalitpur, Nepal
- The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children"Pivotal-lookingCompleted
National Institute of Allergy and Infectious Diseases (NIAID)NIH
NCT01595529 · 717 participants · Start May 18, 2012 · Primary completion Jun 30, 2019
Drug: Cefixime; Cephalexin and 1 more · For: Urinary Tract Infection
Sites: Pittsburgh, Pennsylvania
- Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years OldPivotal-lookingCompleted
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
NCT00136656 · 700 participants · Start Jul 2005 · Primary completion Jun 2008
Drug: antibiotic; antibiotics · For: Pyelonephritis
Sites: Bicêtre, France; Bordeaux, France; Boulogne, France · 12 sites in all
Tata Memorial HospitalGovernment (non-federal)
NCT02830230 · 508 participants (planned) · Start Jul 2016 · Primary completion Dec 2017
Drug: Tab cefixime,Tab Azithromycin · For: Cervical Inflammation and Human Papilloma Virus Performance
Sites: Mumbai, India
- 3-day IV Antibiotic Treatment Versus 3-day IV Followed by 7-day Oral Antibiotic Treatment for AP in ChildrenPivotal-lookingRecruiting
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
NCT05544565 · 480 participants (planned) · Start Mar 22, 2023 · Primary completion Jan 2028
Drug: IV Antibacterial Agents; Orally antibacterial agents · For: Pyelonephritis Acute
Sites: Corbeil-Essonnes, France; Orsay, France; Clamart, France · 15 sites in all
- Cefixime Clinical TrialPivotal-lookingRecruiting
University of Southern CaliforniaAcademic, hospital or other
NCT04958122 · 400 participants (planned) · Start Jun 20, 2021 · Primary completion Jan 1, 2027
Drug: Cefixime 400mg; benzathine penicillin · For: Syphilis; Human Immunodeficiency Virus
Sites: Los Angeles, California
- Optimizing the Diagnostic Approach to Cephalosporin Allergy TestingPivotal-lookingRecruiting
Massachusetts General HospitalAcademic, hospital or other
NCT06406114 · 300 participants (planned) · Start May 5, 2025 · Primary completion Jul 1, 2028
Drug: Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing; Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge and 3 more · For: Drug Allergy; Cephalosporin Allergy; Drug Hypersensitivity and 4 more
Sites: Scottsdale, Arizona; San Francisco, California; Boston, Massachusetts · 6 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- off label use299
- drug ineffective292
- pyrexia175
- diarrhoea174
- nausea173
- pain158
- malaise141
- fatigue138
- headache136
- vomiting136
- dyspnoea134
- abdominal pain117
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 10 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 8 |
| 2008 | 1 |
| 2009 | 9 |
| 2010 | 20 |
| 2011 | 41 |
| 2012 | 43 |
| 2013 | 44 |
| 2014 | 46 |
| 2015 | 55 |
| 2016 | 102 |
| 2017 | 64 |
| 2018 | 137 |
| 2019 | 227 |
| 2020 | 254 |
| 2021 | 281 |
| 2022 | 409 |
| 2023 | 409 |
| 2024 | 328 |
| 2025 | 351 |
| 2026 | 215 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Clinical pharmacokinetics of cefixime: a systematic review.
Ajmal M, Zamir A, Rehman AU, et al. · Xenobiotica 2023 · Systematic Review
- Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Kuehn R, Stoesser N, Eyre D, et al. · Cochrane Database Syst Rev 2022 · Research Support, Non-U.S. Gov't, Systematic Review
- Antibiotics for gonorrhoea in pregnancy.
Brocklehurst P · Cochrane Database Syst Rev 2002 · Systematic Review
- Safety profile of cefixime.
Tally FP, Desjardins RE, McCarthy EF, et al. · Pediatr Infect Dis J 1987 · Clinical Trial
- [Modern pharmacotherapy of acute bacterial sinusitis: results of an open randomized clinical trial of the therapeutic equivalence of Cefixime EXPRESS and Suprax Solutab].
Kryukov AI, Gurov AV, Shadrin GB, et al. · Vestn Otorinolaringol 2024 · Randomized Controlled Trial, Comparative Study
- Effectiveness of Cefixime for the Treatment of Neisseria gonorrhoeae Infection at 3 Anatomic Sites: A Systematic Review and Meta-Analysis.
Yang KJ, Kojima N, Bristow CC, et al. · Sex Transm Dis 2023 · Meta-Analysis, Systematic Review
Sponsor: Lupin LTD
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.